How many times have you started to have a conversation with someone about Hepatitis C only to have it blow up in your face? Have you ever heard someone say something about Hep C that didn't seem quite right to you? You were probably right something was amiss. A discussion about Hepatitis C can...
As per Wikipedia, the definition of a stigma is as follows: "Stigma is a word that originally means a "sign", "point", or "branding mark"." Wikipedia goes on to call stigma "A badge of shame, a physical mark of infamy or disgrace." Damn that w...
Recently, the CDC (Center for Disease Control) issued a statement that all Baby Boomers should be tested for Hepatitis C. The question often comes up as to why this particular segment of people is so vulnerable. What does being born between 1945 and 1965 have to do with Hepatitis C? What was di...
Buyer Beware! There are several snake oil salesmen out there who are claiming to have cured their own Hepatitis C with herbs, supplements and parking lot gravel. Okay, maybe not the parking lot gravel but it might as well be. What you need to remember is that there are two different types of...
Most every adult woman (and an occasional man) has enjoyed a manicure and a pedicure at a nail salon or spa. That 30 minute pedicure can be so relaxing but are you aware of the danger lurking in that nail salon? Although few individuals recognize the medical risks associated with this common pr...
A high quality, rigorous and robust National AIDS Strategic Plan (NSP) that focuses attention on achieving results—including stopping HIV transmission and extending the quality of life of people with HIV—is critical to the success of every national HIV response. The process of developing realistic and adaptable NSPs needs to keep pace with an evolving epidemic and a changing environment.
In Nairobi this week, the World Bank in collaboration with UNAIDS, WHO, UNDP and the Global Fund brought together representatives of National authorities, civil society organisations including people living with HIV and development partners to build consensus on the role and nature of the next generation of National Strategic Plans (so called NSP-3G).
Opening the meeting, the Kenyan Minister of State for Special Programmes, Honourable Esther Murugui, stressed the importance of reviewing National Strategic Plans as a critical means for refining the AIDS response. “As a Government, we recognize the need to develop and adopt systems and structures that match the complexities of the HIV epidemic,” said Minister Murugui. “We have reached a point where we have to change the way we have always done things to a way that focuses on results,” she added.
With a new landscape requiring innovative thinking and approaches, participants explored how new guidance, based on experiences in strategic planning thus far, can support countries in producing simpler, sharper, more effective NSPs that focus on results.
The Representative of the Office of the U.S. Global AIDS Coordinator for PEPFAR, Dr Mamadi Yilla said that “PEPFAR’s hope is that science and evidence drives the approach we take to strategic planning. That the Global AIDS community, that has witnessed constraints to HIV financing commitments, now ensures smarter investments are made.”
Speaking on behalf of the UNAIDS Executive Director, Dr Mbulawa Mugabe pointed out that the Strategic Plans should provide clarity on how to achieve results in line with the 2011 Political Declaration on AIDS goals and commitments. “In the coming years we need to be able to say that progress by 2015 and beyond was underpinned by the NSP-3G,” said Dr Mugabe. “The NSP-3G is the engine that will help countries focus, scale up and reach the 2011 Political Declaration on AIDS targets as well as the commitments made towards the elimination of new HIV infections among children,” he added.
Several key components of NSP-3G emerged during the meeting. This included a move towards a more flexible, adaptive approach to plans that could see HIV programmes integrated into wider health and development strategies. Such a move links closely with the way forward charted at the Fourth High Level Forum on Aid Effectiveness in Busan, Korea in 2011. “We recognise the importance of aligning NSPs more closely to national development planning process; NSPs need to consider decentralisation issues and they should not sit outside of national mechanisms,” explained Mr Daniel Marguari, Director of the Spirita Foundation—an organisation working to improve the quality of life of people living with HIV and their families in Indonesia. “At the same time, we do not want to loose the uniqueness, inclusiveness, partnership and multisectorality of the HIV response, especially when it comes to addressing the needs of key affected populations and communities.”
Participants discussed in detail how real and sustainable country ownership of an effective, multi-sectoral response, with nationally driven strategic plans, can be better achieved. Many national responses in low-and middle-income countries need strengthening. They are often influenced by external development agendas and are still largely funded by international donors. For example in sub-Saharan Africa two-thirds of AIDS expenditures come from external sources.
In order to sustain the HIV response, countries need to make better use of evidence to guide where to invest precious financial and human resources to achieve the HIV targets. Participants explored how countries could mobilize additional funding to meet the financing gap, while increasing efficiencies in the face of declining resources. The UNAIDS Investment Framework was described as a radical and innovative way of looking at resource allocation and closing the funding gap. It sets out to match need with investment, streamlines current strategies to avoid duplication and promotes cost-effectiveness. It supports countries to focus on investment choices that produce results for people.
“Now that our understanding of the HIV epidemic is more scientific and evidence-based, we find ourselves at a stage where we could determine what the exact sets of interventions need to be in a given response to control the epidemic,” Mr Aeneas Chuma, the UN Resident and Humanitarian Coordinator for Kenya said. “This means we need to ask if our investment is directed to the right interventions to achieve the right results.’’
The main outcome of the meeting was the development of ten consensus points on NSP-3G. A support and review group has been established to develop, finalize and disseminate new guidance to countries by October 2012. ‘‘I take note that the current national strategic plan for Kenya comes to an end next year,” said Minister Murugui. “Kenya hereby pledges to lead the world by being the first country to develop a third generation National Strategic Plan that will be based on the guidance that will come out of this important meeting.”
Please sign the ATC Salvage Therapy Petition Join us in asking Congressman Alcee Hastings and Congresswomen Maxine Waters to send a ‘Dear Colleague’ letter to Anthony Fauci, Director of NIAID, asking for the federal facilitation of apricitabine (ATC). ATC is a phase III nucleoside reverse transcriptase inhibitor (NRTI) that has been shown to be safe and effective in treating people with HIV. It works against viruses that are resistant to several other nukes and could ...
Researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School announced today at CROI2013 the discovery of the first infant functionally cured of HIV. The baby, a female now two and a half years old, received 3 HIV medications when brought to the hospital at 30 hours old. Viral load tests were performed during the first few weeks that showed a rapidly decreasing viral load which reached ...
At the 19th International AIDS Conference (AIDS 2012) in Washington D.C., the CDC reported that only 1 out of 4 HIV patients in the U.S. have HIV under control, which is defined as complete viral suppression. Warning bells should be ringing in the scientific and HIV advocacy communities. While much progress has been made in the last three decades in the treatment of HIV, tens of thousands of people living with HIV (PLWH) are currently struggling to construct viable treat...
Paige Rawl is 17 and HIV positive, but while her life has been shaped by HIV it isn't ruled by it. When Paige Rawl starts her senior year at Indianapolis’s Herron High School next month, she'll be cheer captain and a member of the student government and prom committee. This summer, the 17-year-old held down a part-time job at Hollister, hawking the popular Southern California-inspired clothing brand. The all-American girl — who happens to be HIV positive. Paige was in...
The HIV community has been abuzz with the August FDA approval of what had been termed “the Quad”, the second one-pill-once-a-day combination antiretroviral drug. Marketed by Gilead under the name Stribild, the drug contains two NRTIs (tenofovir and emtricitabine), an integrase inhibitor (elvitegravir) and an integrase booster (cobicistat) and is approved for use in treatment naïve patients with either drug resistant or wild type virus. In comparison to Atripla, the first...

Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for SUSTIVA® (efavirenz), including dosing recommendations for...

California and other states would be pressured to amend or repeal criminal laws that single out HIV-positive people under a bipartisan bill co-authored and introduced this week by Rep. Barbara...
Mission Statement
At HIV Haven we wish to provide our readers with vital cutting edge information to help expand HIV knowledge and promote activism, particularly that which works towards an end to the HIV pandemic. It is our desire to bring to you the scientific, medical and social advances that given the appropriate attention and support, could change the course of the HIV pandemic, lessen the devastating effects of HIV and AIDS, better the quality and quantity of life for people living with HIV and even yield an eventual end to the HIV pandemic. We also provide the basics of HIV transmission and treatment.
We will focus on issues such as innovative drug development, strategic activist campaigns, HIV relationships and novel HIV and HIV cure research. We also will bring you advances in Hepatitis C (HCV), a common HIV co-infection. Whether you are living with HIV/AIDS, HIV and HCV, love someone who is, are an activist, advocate, researcher, physician or just an interested party, we hope here at HIV Haven we can help you find what you are looking for.